We are live on ! Find out more
RI

RTW Investments Portfolio holdings

AUM $10B
1-Year Est. Return 135.35%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
+135.35%
3 Year Est. Return
+383.62%
5 Year Est. Return
+523.94%
10 Year Est. Return
+15,981.64%
AUM
$6.91B
AUM Growth
+$452M
Cap. Flow
+$173M
Cap. Flow %
2.51%
Top 10 Hldgs %
46.12%
Holding
78
New
10
Increased
15
Reduced
10
Closed
10

Sector Composition

Rank Sector Weight
1 Healthcare 99.89%
2 Financials 0.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KYTX icon
76
Kyverna Therapeutics
KYTX
$484M
-1,852,711
Closed -$13.9M
CUTR
77
DELISTED
Cutera, Inc.
CUTR
-1,331,776
Closed -$2.01M
ARYD
78
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
-127,970
Closed -$1.47M

Similar funds

RTW Investments's Q3 2024 Portfolio in Review

As of Q3 2024, RTW Investments held 78 positions worth $6.91B, up 7% from $6.46B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

RTW Investments's Q3 2024 filing shows 10 new, 15 increased, 10 reduced and 10 closed positions. Its largest new stake was Geron: 44,111,916 shares worth $200M. The largest sale was Intuitive Surgical, an estimated $90.1M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier, followed by Financials.

  • RTW Investments's largest Q3 2024 buy was Geron: 44,111,916 shares worth $200M.
  • RTW Investments added most to Oruka Therapeutics in Q3 2024, an estimated $60.3M increase.
  • RTW Investments's biggest Q3 2024 reduction was Ultragenyx Pharmaceutical, cutting an estimated $65.8M.
  • RTW Investments fully exited Intuitive Surgical in Q3 2024, selling an estimated $90.1M.
  • RTW Investments's ten largest holdings make up 46% of its $6.91B portfolio in Q3 2024.
  • RTW Investments opened 10 new positions and closed 10 in Q3 2024.
  • RTW Investments's portfolio value rose 7% quarter-over-quarter to $6.91B.

Based on RTW Investments's 13F filing for Q3 2024, filed 14 Nov 2024.